GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Cyclically Adjusted Price-to-FCF

Edwards Lifesciences (LTS:0REN) Cyclically Adjusted Price-to-FCF : 66.29 (As of Jun. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted Price-to-FCF?

As of today (2024-06-04), Edwards Lifesciences's current share price is CHF77.55964. Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was CHF1.17. Edwards Lifesciences's Cyclically Adjusted Price-to-FCF for today is 66.29.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LTS:0REN' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.33   Med: 69.21   Max: 113.15
Current: 61.12

During the past years, Edwards Lifesciences's highest Cyclically Adjusted Price-to-FCF was 113.15. The lowest was 36.33. And the median was 69.21.

LTS:0REN's Cyclically Adjusted Price-to-FCF is ranked worse than
68.35% of 237 companies
in the Medical Devices & Instruments industry
Industry Median: 43.21 vs LTS:0REN: 61.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Edwards Lifesciences's adjusted free cash flow per share data for the three months ended in Mar. 2024 was CHF-0.204. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is CHF1.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted Price-to-FCF Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.88 97.20 108.59 54.10 52.26

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.86 66.13 46.94 52.26 66.48

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted Price-to-FCF falls into.



Edwards Lifesciences Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Edwards Lifesciences's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=77.55964/1.17
=66.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Edwards Lifesciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.204/131.7762*131.7762
=-0.204

Current CPI (Mar. 2024) = 131.7762.

Edwards Lifesciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.059 100.560 1.388
201409 -0.009 100.428 -0.012
201412 0.071 99.070 0.094
201503 0.078 99.621 0.103
201506 0.214 100.684 0.280
201509 0.260 100.392 0.341
201512 0.094 99.792 0.124
201603 0.119 100.470 0.156
201606 0.167 101.688 0.216
201609 0.234 101.861 0.303
201612 0.215 101.863 0.278
201703 0.169 102.862 0.217
201706 0.203 103.349 0.259
201709 0.408 104.136 0.516
201712 0.465 104.011 0.589
201803 0.154 105.290 0.193
201806 0.135 106.317 0.167
201809 0.389 106.507 0.481
201812 0.367 105.998 0.456
201903 -0.090 107.251 -0.111
201906 0.418 108.070 0.510
201909 0.562 108.329 0.684
201912 0.510 108.420 0.620
202003 0.189 108.902 0.229
202006 0.189 108.767 0.229
202009 0.164 109.815 0.197
202012 0.397 109.897 0.476
202103 0.286 111.754 0.337
202106 0.658 114.631 0.756
202109 0.688 115.734 0.783
202112 0.408 117.630 0.457
202203 0.326 121.301 0.354
202206 0.448 125.017 0.472
202209 0.390 125.227 0.410
202212 0.293 125.222 0.308
202303 0.363 127.348 0.376
202306 -0.002 128.729 -0.002
202309 0.526 129.860 0.534
202312 0.050 129.419 0.051
202403 -0.204 131.776 -0.204

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (LTS:0REN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Edwards Lifesciences Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (LTS:0REN) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines